News

Latest News

Latest Press Releases

HPS2-THRIVE: Key Results Presented

Niacin causes serious unexpected side-effects, but no worthwhile benefits, for patients who are at increased risk of heart attack and strokes.

Longer use of tamoxifen improves breast cancer survival

Taking the drug tamoxifen for ten years after breast cancer surgery, rather than the usual five, further reduces the chances of dying from breast cancer.

UK Biobank opens for research

An incredible snapshot of the health and lifestyles of 500,000 Britons is now available for medical research. And it is all thanks to the generous people who have taken part in UK Biobank.

See BMJ video about UK Biobank

Successful initiation of the REVEAL trial of anacetrapib in high-risk vascular patients

Over 20,000 people have now been recruited into this important international study.

CTSU

Clinical Trial Service Unit and Epidemiological Studies Unit